nystatin-a1 and Papillomavirus-Infections

nystatin-a1 has been researched along with Papillomavirus-Infections* in 2 studies

Other Studies

2 other study(ies) available for nystatin-a1 and Papillomavirus-Infections

Article	Year
[Researching the effectiveness and the relevancy of combined therapy with Polygynax and Pharmatex in the cases with proved HPV infection or suspicion of such infection]. Akusherstvo i ginekologiia, 2011, Volume: 50 Suppl 2 The HPV infection is the most frequent sexually transmitted disease. It can be estimated that approximately 80% of young women would be infected with it till their fiftieth anniversary. When there is a HPV infection in the zone of the external sexual organs and the introitus, in 90% of the cases, the cervix is also engaged. In the majority of the cases, there is a parallel fungal infection with often presence of bacterial component which sets the low local immunity and creates ideal environment for HPV infection. This fact serves as basis for the application of the therapeutic combination of Polygynax+Pharmatex at this first stage. Relying on the virucide action of the local non-hormonal contraception - Pharmatex and the wide action range of Polygynax, the present clinical research confirmed the rightfulness of our thesis and the efficiency of the suggested therapeutic model. Topics: Adult; Antiviral Agents; Arsenicals; Contraceptive Agents; Drug Combinations; Female; Genital Diseases, Female; Humans; Neomycin; Nystatin; Papillomaviridae; Papillomavirus Infections; Polymyxins; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral; Young Adult	2011
[Conservative treatment of women with genital HPV. Results of Polygynax and Pharmatex combination]. Akusherstvo i ginekologiia, 2007, Volume: 46 Suppl 2 Topics: Arsenicals; Contraceptive Agents, Female; Drug Combinations; Female; Genital Diseases, Female; Genitalia, Female; Humans; Neomycin; Nystatin; Papillomavirus Infections; Polymyxins	2007

Article

Year

[Researching the effectiveness and the relevancy of combined therapy with Polygynax and Pharmatex in the cases with proved HPV infection or suspicion of such infection].

Akusherstvo i ginekologiia, 2011, Volume: 50 Suppl 2

The HPV infection is the most frequent sexually transmitted disease. It can be estimated that approximately 80% of young women would be infected with it till their fiftieth anniversary. When there is a HPV infection in the zone of the external sexual organs and the introitus, in 90% of the cases, the cervix is also engaged. In the majority of the cases, there is a parallel fungal infection with often presence of bacterial component which sets the low local immunity and creates ideal environment for HPV infection. This fact serves as basis for the application of the therapeutic combination of Polygynax+Pharmatex at this first stage. Relying on the virucide action of the local non-hormonal contraception - Pharmatex and the wide action range of Polygynax, the present clinical research confirmed the rightfulness of our thesis and the efficiency of the suggested therapeutic model.

Topics: Adult; Antiviral Agents; Arsenicals; Contraceptive Agents; Drug Combinations; Female; Genital Diseases, Female; Humans; Neomycin; Nystatin; Papillomaviridae; Papillomavirus Infections; Polymyxins; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral; Young Adult

2011

[Conservative treatment of women with genital HPV. Results of Polygynax and Pharmatex combination].

Akusherstvo i ginekologiia, 2007, Volume: 46 Suppl 2

Topics: Arsenicals; Contraceptive Agents, Female; Drug Combinations; Female; Genital Diseases, Female; Genitalia, Female; Humans; Neomycin; Nystatin; Papillomavirus Infections; Polymyxins

2007